|
AU2004242533A1
|
|
Large circular target-specific antisense nucleic acid compounds
|
|
AU2003260820A1
|
|
Nephritis treatment by gene therapy
|
|
KR20040011602A
|
|
DNA chip using a probe DNA with single stranded large circular molecules
|
|
CA2370324A1
|
|
Large circular target-specific antisense nucleic acid compounds
|
|
KR20030065053A
|
|
Peptides increasing the transfer efficiency of DNA into cell or tissue
|
|
KR20030056538A
|
|
EFFECTIVE INHIBITION OF TRANSFORMING GROWTH FACTOR-β1 BY A RIBBON-TYPE ANTISENSE OLIGONUCLEOTIDE
|
|
AU2001294331A1
|
|
Method for preparing antisense molecules by using bacteriophages with closed single stranded genome and novel antisense molecules produced thereby
|
|
KR20020068450A
|
|
Novel method for high-throughput screening and functional analysis of genes using antisense library consisted of unigene antisense molecules
|
|
KR20020076001A
|
|
Recombinant virus vector expressing human IL-10 effective for inhibition of glomerulosclerosis and a gene therapy using them for curing renal failure
|
|
KR20020067959A
|
|
Novel high-throughput system for functional genomics using unidirectional antisense cdna library
|
|
KR20020011555A
|
|
Methods preparing antisense molecules using bacteriophages with closed single stranded genome and novel antisense molecules produced thereby
|
|
KR20020013527A
|
|
The novel antisense-oligos with better stability and antisense effect
|
